PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.520.06 (-1.08%)
5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.67%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.16%
Negative gross profit growth while UPM.HE is at 104.85%. Joel Greenblatt would examine cost competitiveness or demand decline.
-18.75%
Negative EBIT growth while UPM.HE is at 149.03%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-18.75%
Negative operating income growth while UPM.HE is at 149.03%. Joel Greenblatt would press for urgent turnaround measures.
-51.01%
Negative net income growth while UPM.HE stands at 155.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-46.67%
Negative EPS growth while UPM.HE is at 156.67%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-46.67%
Negative diluted EPS growth while UPM.HE is at 156.67%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-8.14%
Share reduction while UPM.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-8.14%
Reduced diluted shares while UPM.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
65.77%
OCF growth above 1.5x UPM.HE's 12.04%. David Dodd would confirm a clear edge in underlying cash generation.
266.79%
FCF growth above 1.5x UPM.HE's 10.85%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-23.89%
Negative 10Y revenue/share CAGR while UPM.HE stands at 10.70%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-27.08%
Negative 5Y CAGR while UPM.HE stands at 4.75%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-30.20%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
30.50%
10Y OCF/share CAGR under 50% of UPM.HE's 214.74%. Michael Burry would worry about a persistent underperformance in cash creation.
540.99%
5Y OCF/share CAGR above 1.5x UPM.HE's 7.86%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
103.03%
3Y OCF/share CAGR above 1.5x UPM.HE's 12.11%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
133.33%
Net income/share CAGR at 50-75% of UPM.HE's 261.88%. Martin Whitman might question if the firm’s product or cost base lags behind.
-31.58%
Negative 5Y net income/share CAGR while UPM.HE is 123.40%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
150.00%
Below 50% of UPM.HE's 1118.03%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
-2.03%
Negative 5Y equity/share growth while UPM.HE is at 11.86%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-7.88%
Negative 3Y equity/share growth while UPM.HE is at 5.25%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.50%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-4.03%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.55%
Asset growth above 1.5x UPM.HE's 0.95%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
9.74%
BV/share growth above 1.5x UPM.HE's 4.10%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.18%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-17.61%
We cut SG&A while UPM.HE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.